INBS
Intelligent Bio Solutions Inc.NASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$5.36M
P/E Ratio
—
EPS
$-14.73
Beta
4.59
52W High
$24.90
52W Low
$2.46
50-Day MA
$4.92
200-Day MA
$10.61
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (INBS) is a forward-thinking biotechnology company committed to revolutionizing healthcare through the development of innovative diagnostic solutions and biomarker-driven technologies, especially in the realm of drug abuse testing and monitoring. Leveraging cutting-edge scientific advancements, the company aims to enhance healthcare outcomes by offering highly accurate and rapid-testing methodologies that facilitate timely clinical decision-making. Positioned strategically at the nexus of technology and healthcare, INBS is well-positioned to capitalize on the growing demand for advanced diagnostic tools in a dynamic market landscape.
Fundamentals
| Revenue (TTM) | $3.58M |
| Gross Profit (TTM) | $1.66M |
| EBITDA | $-9.84M |
| Operating Margin | -290.90% |
| Return on Equity | -150.20% |
| Return on Assets | -51.20% |
| Revenue/Share (TTM) | $4.65 |
| Book Value | $8.96 |
| Price-to-Book | 0.50 |
| Price-to-Sales (TTM) | 1.50 |
| EV/Revenue | 1.867 |
| EV/EBITDA | -0.91 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 47.60% |
| Shares Outstanding | $2.00M |
| Float | $1.59M |
| % Insiders | 4.27% |
| % Institutions | 0.28% |
Data last updated: 4/8/2026